As a result, inhibition of acetylcholinesterase (AChE), the enzyme responsible for the breakdown of ACh in the brain, is the mode of action of the currently used, FDA approved anti-AD drugs, namely rivastigmine, galantamine and donepezil. This evidence concerns the gene ACHE and Alzheimer disease.